Presentation Information

[S06-02]Development of Vaccines and Immunotherapy Using Alphaviruses

○Wataru Akahata1,2 (1. VLP Therapeutics, Inc. (United States of America), 2. VLP Therapeutics Japan, Inc. (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in